Fluphenazine octanoate

Get a Price/Quote

MOQ : 1 , , Kilograms

Fluphenazine octanoate Specification

Molecular Formula
C30H40F3N3O2S

Molecular Weight
563.7 Grams (g)

Usage
Fluphenazine Decanoate Injection, USP is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics).

Purity
98%

Appearance
pale yellow to yellow orange viscous liquid

Fluphenazine octanoate Trade Information

Minimum Order Quantity
1 , , Kilograms

Payment Terms
Cash in Advance (CID), Cash Advance (CA)

Supply Ability
500 Kilograms Per Month

Delivery Time
3-4 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Main Export Market(s)
Asia, Australia, North America, Eastern Europe, Western Europe, Middle East, Africa, South America, Central America

Main Domestic Market
All India

About Fluphenazine octanoate

Fluphenazine Octanoate is a high-purity antipsychotic compound (98%) with a molecular formula of C30H40F3N3O2S and a molecular weight of 563.7 grams. It appears as a pale yellow to yellow-orange viscous liquid. This compound is primarily utilized as an active ingredient in Fluphenazine Decanoate Injection, USPa long-acting parenteral antipsychotic medication. It is designed for the effective management of patients requiring extended neuroleptic therapy, particularly those diagnosed with chronic schizophrenia. With its stable formulation and reliable efficacy, this compound serves as a critical asset in the production of neuroleptic solutions for sustained mental health treatment.

FAQs of Fluphenazine octanoate:

Q: What is the appearance of Fluphenazine Octanoate?

A: Fluphenazine Octanoate appears as a pale yellow to yellow-orange viscous liquid.

Q: What is the primary use of Fluphenazine Octanoate?

A: It is used in Fluphenazine Decanoate Injection, a long-acting antipsychotic drug for the management of patients requiring extended neuroleptic therapy, such as chronic schizophrenics.